|
[1]
|
Shibata, R., Ouchi, N. and Murohara, T. (2009) Adiponectin and Cardiovascular Disease. Circulation Journal, 73, 608-614. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Ziemke, F. and Mantzoros, C.S. (2010) Adiponectin in Insulin Resistance: Lessons from Translational Research. The American Journal of Clinical Nutrition, 91, 258S-261S. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Hu, P., Bao, J. and Wu, L. (2011) The Emerging Role of Adipokines in Osteoarthritis: A Narrative Review. Molecular Biology Reports, 38, 873-878. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Mitsiades, N., Pazaitou-Panayiotou, K., Aronis, K.N., Moon, H., Chamberland, J.P., Liu, X., et al. (2011) Circulating Adiponectin Is Inversely Associated with Risk of Thyroid Cancer: In Vivo and in Vitro Studies. The Journal of Clinical Endocrinology & Metabolism, 96, E2023-E2028. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Chiarugi, P. and Fiaschi, T. (2010) Adiponectin in Health and Diseases: From Metabolic Syndrome to Tissue Regeneration. Expert Opinion on Therapeutic Targets, 14, 193-206. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Chen, X. and Wang, Y. (2011) Adiponectin and Breast Cancer. Medical Oncology, 28, 1288-1295. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
赵慧敏, 雷自立, 郭姣. 脂联素水平与2型糖尿病及心血管疾病矛盾性关系的研究进展[J]. 中国细胞生物学学报, 2018, 40(5): 820-826.
|
|
[8]
|
Schulze, M.B., Rimm, E.B., Shai, I., Rifai, N. and Hu, F.B. (2004) Relationship between Adiponectin and Glycemic Control, Blood Lipids, and Inflammatory Markers in Men with Type 2 Diabetes. Diabetes Care, 27, 1680-1687. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Festa, A., D’agostino, R., Howard, G., Mykkänen, L., Tracy, R.P. and Haffner, S.M. (2000) Inflammation and Microalbuminuria in Nondiabetic and Type 2 Diabetic Subjects: The Insulin Resistance Atherosclerosis Study. Kidney International, 58, 1703-1710. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Becker, B., Kronenberg, F., Kielstein, J.T., Haller, H., Morath, C., Ritz, E., et al. (2005) Renal Insulin Resistance Syndrome, Adiponectin and Cardiovascular Events in Patients with Kidney Disease. Journal of the American Society of Nephrology, 16, 1091-1098. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
林旋, 郎江明, 魏爱生, 等. 健康体检人群甲状腺结节发病危险因素的病例对照研究[J]. 广东医学, 2018, 39(4): 604-607.
|
|
[12]
|
Dalamaga, M., Diakopoulos, K.N. and Mantzoros, C.S. (2012) The Role of Adiponectin in Cancer: A Review of Current Evidence. Endocrine Reviews, 33, 547-594. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Kaklamani, V., Yi, N., Zhang, K., Sadim, M., Offit, K., Oddoux, C., et al. (2011) Polymorphisms of ADIPOQ and ADIPOR1 and Prostate Cancer Risk. Metabolism, 60, 1234-1243. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Ollberding, N.J., Kim, Y., Shvetsov, Y.B., Wilkens, L.R., Franke, A.A., Cooney, R.V., et al. (2013) Prediagnostic Leptin, Adiponectin, C-Reactive Protein, and the Risk of Postmenopausal Breast Cancer. Cancer Prevention Research, 6, 188-195. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Gulcelik, M.A., Colakoglu, K., Dincer, H., Dogan, L., Yenidogan, E. and Gulcelik, N.E. (2012) Associations between Adiponectin and Two Different Cancers: Breast and Colon. Asian Pacific Journal of Cancer Prevention, 13, 395-398. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
陈学敏, 胡明军, 何年安. 67505例甲状腺结节超声检查结果分析[J]. 安徽医学, 2023, 44(10): 1227-1230.
|